| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $47,483,133 ) (Continued on the next page) |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 90AREM0006 | ARRT - Equitable Employment across Evolving Work Paradigms | 00 | 3 | ACL | 3/31/2025 | $199,996 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EB033580 | Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer | 001 | 4 | NIH | 5/19/2025 | $0 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EB033580 | Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer | 000 | 4 | NIH | 11/7/2024 | $174,342 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01NS126183 | Hierarchically-Structured Conduits with Programmed Release of Neurotrophic Factors for Repairing Large Defects in Thick Nerves | 000 | 3 | NIH | 5/7/2025 | $440,388 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM145350 | Illuminating Heme Trafficking and Signaling Pathways in Health and Disease | 002 | 4 | NIH | 8/13/2025 | $37,471 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM145350 | Illuminating Heme Trafficking and Signaling Pathways in Health and Disease | 001 | 4 | NIH | 3/20/2025 | $337,241 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R25GM142044 | Frugal Science Academy: Training K-12 innovators and democratizing synthetic biology tools | 002 | 4 | NIH | 7/11/2025 | $259,948 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB034359 | Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback | 001 | 3 | NIH | 6/25/2025 | $64,122 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB034359 | Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback | 000 | 3 | NIH | 3/21/2025 | $577,104 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01DK133702 | Hydrogels for human beta cell survival, function and evasion of immune rejection | 000 | 4 | NIH | 5/28/2025 | $784,733 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21DE034938 | Controlled delivery of mitochondria for craniofacial bone healing | 000 | 1 | NIH | 7/17/2025 | $447,009 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | RF1AG096055 | Identifying Multi-Scale Mechanisms for Age-Related Increase in Metabolic Cost of Walking | 000 | 1 | NIH | 8/8/2025 | $3,224,215 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | T32GM145735 | T32 CTEng (Cellular and Tissue Engineering) Training Program | 000 | 4 | NIH | 6/16/2025 | $481,905 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HD104825 | Regulation of neurodevelopmental cell behaviors in Ciona | 000 | 4 | NIH | 6/17/2025 | $311,572 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | S10OD038327 | Bruker timsTOF HT Mass Spectrometer to Support Proteomics Research in the Georgia Tech Core Facilities | 000 | 1 | NIH | 4/29/2025 | $150,000 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | S10OD038327 | Bruker timsTOF HT Mass Spectrometer to Support Proteomics Research in the Georgia Tech Core Facilities | 000 | 1 | NIH | 4/29/2025 | $600,000 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB032822 | Image-guided cancer therapy using heat activatable CAR T cells | 000 | 4 | NIH | 7/24/2025 | $636,385 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA266052 | Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway Inhibitors | 000 | 4 | NIH | 7/17/2025 | $547,532 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM143070 | Studying temporal dynamics and regulatory mechanisms of single cells with a unified framework and multi-omics data | 000 | 5 | NIH | 8/11/2025 | $346,684 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01DK128840 | BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION | 000 | 5 | NIH | 7/15/2025 | $250,384 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL179060 | Engineered biomaterials for promoting lymphatic regeneration in lymphedema | 000 | 1 | NIH | 6/3/2025 | $502,294 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM142588 | Biophysical mechanism and synthetic engineering of optically-controlled Ca2+-powered supramolecular engines | 000 | 5 | NIH | 6/26/2025 | $395,500 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01DC020048 | Discovering novel predictors of minimally verbal outcomes in autism through computational modeling | 000 | 4 | NIH | 6/3/2025 | $528,977 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AG073434 | Characterizing Alzheimer's Amyloid-beta Oligomer Structures by Solid-State NMR and Cryo-Electron Microscopy | 001 | 2 | NIH | 7/16/2025 | $33,233 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AG073434 | Characterizing Alzheimer's Amyloid-beta Oligomer Structures by Solid-State NMR and Cryo-Electron Microscopy | 000 | 2 | NIH | 5/1/2025 | $440,852 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HG011459 | Precision mapping of regulatory causal variants by expression CROPseq | 001 | 5 | NIH | 4/25/2025 | $68,232 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HG011459 | Precision mapping of regulatory causal variants by expression CROPseq | 000 | 5 | NIH | 3/20/2025 | $614,078 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01NS128896 | Feedback and feedforward gating of sensory signaling through timing in the thalamocortical loop | 000 | 2 | NIH | 8/5/2025 | $480,841 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI187618 | Characterization of P. aeruginosa sRNAs that are highly expressed in human chronic infections | 000 | 1 | NIH | 7/25/2025 | $775,184 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21AI193884 | Deep Learning-Driven Biodosimetry for High-Throughput Radiation Triage via Chromosomal Aberration Detection | 000 | 1 | NIH | 7/31/2025 | $157,400 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21EB037156 | Real-Time Monitoring and Automated Electrolyte Repletion Using Ion-Selective, Sensor-Integrated Central Venous Catheters | 000 | 1 | NIH | 8/6/2025 | $418,284 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01NS147739 | CRCNS: The Circuit Mechanism of Sensorimotor Predictive Processing for Active Touch | 000 | 1 | NIH | 7/30/2025 | $377,602 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA252720 | Reposition and Optimization of Deferiprone for Breast Cancer Therapy | 002 | 5 | NIH | 5/22/2025 | $39,947 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA252720 | Reposition and Optimization of Deferiprone for Breast Cancer Therapy | 001 | 5 | NIH | 5/2/2025 | $0 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA252720 | Reposition and Optimization of Deferiprone for Breast Cancer Therapy | 000 | 5 | NIH | 2/12/2025 | $359,532 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | K22AI173181 | Protective impacts of commensal protists on the human gut microbiome | 000 | 2 | NIH | 2/12/2025 | $107,129 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31AI191664 | Investigating R-pyocins as a therapeutic approach to treat high-risk, multidrug-resistant Pseudomonas aeruginosa wound infections | 001 | 1 | NIH | 7/23/2025 | $0 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31AI191664 | Investigating R-pyocins as a therapeutic approach to treat high-risk, multidrug-resistant Pseudomonas aeruginosa wound infections | 000 | 1 | NIH | 7/23/2025 | $49,538 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB034301 | Synthetic biological systems for protein detection | 001 | 3 | NIH | 6/25/2025 | $35,595 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB034301 | Synthetic biological systems for protein detection | 000 | 3 | NIH | 2/18/2025 | $320,355 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL173943 | LYMPHEDEMA THERAPY VIA LYMPHATIC TARGETED DRUG DELIVERY | 000 | 2 | NIH | 2/28/2025 | $549,620 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | T32EB021962 | T32 Research Training Program in ImmunoEngineering | 000 | 8 | NIH | 5/28/2025 | $217,824 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM150689 | Engineering Tissue Level Targeting of Biologic Drugs via Automated Interfacial Microneedle Pumps | 000 | 3 | NIH | 7/17/2025 | $393,500 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01GM149693 | Bioorthogonal methods for unveiling chemical reactivity | 000 | 2 | NIH | 7/18/2025 | $317,623 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R33CA291197 | Spatial protein-protein interaction networks in situ by multiplexed proximity ligation | 000 | 2 | NIH | 7/15/2025 | $374,123 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM150890 | Integrative deep learning algorithms for understanding protein sequence-structure-function relationships: representation, prediction, and discovery | 000 | 3 | NIH | 8/4/2025 | $362,878 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R37CA289714 | Engineering ingestible nanosensors for breath-based detection of colorectal cancer | 000 | 1 | NIH | 3/11/2025 | $592,866 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R37CA239039 | TRANSCRANIAL FUS THERAPY WITH CLOSED-LOOP US IMAGE GUIDANCE AND CIRCULATING | 000 | 6 | NIH | 5/14/2025 | $452,110 |
| | 2025 | 2025 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | U01CA280984 | Dysregulated mechanoimmunology of epigenetics-driven lymphomas | 000 | 3 | NIH | 6/18/2025 | $518,073 |
|
